Press Release Description

Surging Infertility Cases to Augment the UAE In Vitro Fertilization (IVF) Market During 2022-2027

The UAE In Vitro Fertilization (IVF) Market is projected to grow at a CAGR of around 14.12% in the forecast period of 2022-27, says MarkNtel Advisors in their recent research report. The rising number of infertility cases among both genders is one of the prominent reasons for the growing inclination of expectant parents toward the adoption of In Vitro Fertilization (IVF) treatment in the country. Additionally, delayed pregnancies & the growing number of working women population are also considered the key factors contributing to the growth of IVF in the UAE. In addition, the upsurge in reproductive tourism due to the rising government initiatives & healthcare infrastructural development, generating the demand for equipment, consumables, reagents, and media in the country. Furthermore, a digital platform has been launched by the Department of Health Abu Dhabi & the Department of Culture and Tourism to provide all the medical offerings related to fertility/infertility treatments to cater to the international patients’ queries & requirements.

However, in 2020, due to the imposed lockdown, social distancing norms, and the temporary closing of clinics & fertility centers across the country, had a substantial influence on the UAE In Vitro Fertilization (IVF) Market. As a result, several continuing IVF operations had to endure a lot of hardship during that time. Because IVF is a time-sensitive industry, every week is critical for couples undergoing the procedure. Besides, postponed procedures & an increase in coronavirus infections have had a substantial impact on clinics & fertility services such as IVF & egg freezing.

Additionally, the country allows gender recognition of the embryo before pregnancy to maintain the family balance by the would-be parents. Hence, there is a paradigm shift towards the adoption of IVF treatments to have the gender selection option & earlier diagnosis of any hereditary & chromosomal disorder in the human embryo. Further, the growing government initiatives to provide free IVF treatments for the underprivileged infertile population of the country to maintain a healthy population ratio would propel the In Vitro Fertilization (IVF) Market during the forecasted years, further states the research report, "UAE In Vitro Fertilization (IVF) Market Analysis, 2027F."

Intracytoplasmic Sperm Injection (ICSI) to Dominate the Market

Based on the type, the market is divided into Conventional IVF & Intracytoplasmic Sperm Injection (ICSI). Among them, Intracytoplasmic Sperm Injection (ICSI) dominates the market on account of its exploded popularity over the last few years & is predicted to have an astonishing market growth. Moreover, the technology was originally formulated to overcome male infertility difficulties such as low sperm count & immotile sperms. Furthermore, the ICSI procedure fertilizes an average of 50-80 percent of the injected eggs, whereas the traditional IVF procedure fertilizes around 50% of the eggs. As a result, ICSI is widely used within fertility clinics & hospitals to perform IVF treatments, owing to the increasing potential to yield good reproductive results & rapidly increasing success rates.

Dubai & Abu Dhabi to Have a Significant Market Growth During 2022-2027

Depending upon the regional landscape, Dubai & Abu Dhabi accounted for a dominant share in the historical years & are expected to have a significant market growth during the forecasted years. The rising infrastructural development of fertility clinics, reproductive care, and hospitals in both regions is one of the fueling factors of the IVF market growth in the UAE. Moreover, the growing burden of secondary infertility cases due to overweight or underweight problems, hormonal conditions, and advanced aging in Dubai & Abu Dhabi have further augmented the demand for IVF treatment in the forecasted year.

In addition, the Canadian Specialist Hospital, NMC Royal Women's Hospital, Orchid Fertility Clinic, and Fakih IVF Fertility Centre are among the leading hospitals & specialist fertility centers in their respective countries. Furthermore, the growing number of partnerships for developing infertility centers in the country, advancements in healthcare technologies, and growing reproductive tourism would stimulate the market in the coming years, reveals MarkNtel Advisors in their research report, "UAE In Vitro Fertilization (IVF) Market Analysis, 2027F."

Key Competitors

According to MarkNtel Advisors, the leading players in the UAE In Vitro Fertilization (IVF) Market are CooperSurgical Fertility, Vitrolife, Esco Medical, Merck Group, Microptic Automatic Diagnostic Systems, Al Hayat Pharmaceuticals, Biomerieux, Eppendorf, and Others.

Key Questions Answered in the Study

  1. What are the current & future trends in the UAE In Vitro Fertilization (IVF) Market?
  2. How has the industry been evolving in terms of geography & product adoption?
  3. How has the competition been shaping across various countries, followed by their comparative landscape?
  4. What are the key growth drivers & challenges for the UAE In Vitro Fertilization (IVF) Market?
  5. What are the customer orientation, purchase behavior, and expectations from product providers across various regions?

Market Segmentation:

  1. By Type (Conventional IVF, Intracytoplasmic Sperm Injection (ICSI))
  2. By Reagents & Media (Cryopreservation Media, Embryo Culture Media, Sperm Processing Media, Ovum Processing Media)
  3. By Equipment (Sperm Separation System, Ovum Aspiration Pumps, Micromanipulator Systems, Imaging Systems, Gas Analyzers, Laser Systems, Cryosystems, Others (Cabinets, anti-vibration table, accessories, etc.))
  4. By Consumables (Culture Dishes, ICSI and Biopsy Dishes, Multiwell Dishes, Oocyte Retrieval Needles, ET Catheters and Syringes, Others (Conical tubes, micropipettes, etc.))
  5. By End User (Fertility Units, Hospitals, Surgical Centers, Research Centers)
  6. By Region (Dubai, Abu Dhabi, Sharjah, and the Northern Emirates)
  7. By Company (CooperSurgical Fertility, Vitrolife, Esco Medical, Merck Group, Microptic Automatic Diagnostic Systems, Al Hayat Pharmaceuticals, Biomerieux, Eppendorf, Others)